Research Articles
A Cellular Tug-of-War: How a New Drug Could Outsmart a Tenacious Blood Cancer
Discover how Aurkin-A, a novel TPX2-Aurora A inhibitor, disrupts alisertib-induced polyploidy in high-grade diffuse large B-cell lymphoma, offering new hope for cancer treatment.
Taming a Silent Invader: How a "Double-Bladed" Antibody Awakens the Body's Army
Explore how locoregional immunotherapy using bispecific antibodies and CD28 costimulation is revolutionizing low-grade B-cell lymphoma treatment.
Valdien and the Battle Within: Reigniting Cellular Suicide in Lymphoma Cells
Exploring how Valdien, a novel compound, combats Non-Hodgkin's Lymphoma by reactivating apoptosis in cancer cells through targeted molecular mechanisms.
A Dynamic Duo: Supercharging the Immune System to Fight Cancer
Discover how combining immunomodulatory drugs with targeted antibodies creates a powerful one-two punch against lymphoma in recent research.
A Natural Sniper: How Wogonin Targets EBV-Positive Lymphoma
Discover how the plant compound Wogonin precisely targets Epstein-Barr virus positive lymphoma cells through the LMP1/NF-κB/miR-155/PU.1 pathway
Halting the Rogue Cells: How a Molecular Wrench Could Stop a Rare Cancer
Exploring how proteasome inhibitor MG132 affects NK/T cell lymphoma cells by disrupting their protein recycling system and inducing cell cycle arrest.
Silencing the Traitor Within: How Starving Lymphoma Cells of BDNF Triggers Their Self-Destruction
Discover how knocking down BDNF in B-cell lymphoma cells induces cell cycle arrest and apoptosis, offering new therapeutic strategies.